[go: up one dir, main page]

SE9000595D0 - New peptides, diagnostic antigens and an immunoassay method - Google Patents

New peptides, diagnostic antigens and an immunoassay method

Info

Publication number
SE9000595D0
SE9000595D0 SE9000595A SE9000595A SE9000595D0 SE 9000595 D0 SE9000595 D0 SE 9000595D0 SE 9000595 A SE9000595 A SE 9000595A SE 9000595 A SE9000595 A SE 9000595A SE 9000595 D0 SE9000595 D0 SE 9000595D0
Authority
SE
Sweden
Prior art keywords
antigen
immunoassay method
peptides
new peptides
diagnostic
Prior art date
Application number
SE9000595A
Other languages
English (en)
Other versions
SE9000595L (sv
SE468168B (sv
Inventor
J Blomberg
Original Assignee
Replico Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Ab filed Critical Replico Ab
Priority to SE9000595A priority Critical patent/SE468168B/sv
Publication of SE9000595D0 publication Critical patent/SE9000595D0/sv
Priority to PCT/SE1991/000114 priority patent/WO1991013360A1/en
Priority to AU74448/91A priority patent/AU7444891A/en
Publication of SE9000595L publication Critical patent/SE9000595L/sv
Publication of SE468168B publication Critical patent/SE468168B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9000595A 1990-02-20 1990-02-20 Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov SE468168B (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9000595A SE468168B (sv) 1990-02-20 1990-02-20 Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
PCT/SE1991/000114 WO1991013360A1 (en) 1990-02-20 1991-02-18 NEW HIV p24 PEPTIDES, DIAGNOSTIC ANTIGENS AND DISCRIMINATIVE IMMUNOASSAY METHOD
AU74448/91A AU7444891A (en) 1990-02-20 1991-02-18 New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000595A SE468168B (sv) 1990-02-20 1990-02-20 Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov

Publications (3)

Publication Number Publication Date
SE9000595D0 true SE9000595D0 (sv) 1990-02-20
SE9000595L SE9000595L (sv) 1991-08-21
SE468168B SE468168B (sv) 1992-11-16

Family

ID=20378616

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000595A SE468168B (sv) 1990-02-20 1990-02-20 Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov

Country Status (3)

Country Link
AU (1) AU7444891A (sv)
SE (1) SE468168B (sv)
WO (1) WO1991013360A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
SE9101863D0 (sv) * 1991-06-13 1991-06-13 Replico Medical Ab Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
JP2002533124A (ja) 1998-12-31 2002-10-08 カイロン コーポレイション Ｈｉｖポリペプチドの改善された発現およびウイルス様粒子の生成
AU2596600A (en) 1998-12-31 2000-07-31 Chiron Corporation Modified hiv env polypeptides
NO311807B1 (no) 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
AU785143B2 (en) * 2000-02-04 2006-10-05 Beth Israel Deaconess Medical Center Human immunodeficiency virus vaccine
NO314588B1 (no) 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2013273483A1 (en) 2012-06-06 2014-12-11 Bionor Immuno As Vaccine
JP2017523166A (ja) 2014-07-11 2017-08-17 ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ ヒト免疫不全ウイルスｉ（ｈｉｖ）の病理学的影響を減少及び／若しくは遅延させるか又は後天性免疫不全症候群（ａｉｄｓ）を発症するリスクを低減させる方法
JP2018515603A (ja) 2015-05-04 2018-06-14 ビオノル・イムノ・アクシェセルスカプＢｉｏｎｏｒ Ｉｍｍｕｎｏ ＡＳ Ｈｉｖワクチン用の投薬レジメン

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122005000039I1 (de) * 1984-10-18 2006-02-23 Pasteur Institut DNS-Fragmente des GAG-Gens von LAV
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
ATE116006T1 (de) * 1985-04-29 1995-01-15 Genetic Systems Corp Synthetische antigene zum nachweis von aids.
US4808536A (en) * 1986-02-27 1989-02-28 Centocor, Inc. Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
CA1339363C (en) * 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
DE68925909T2 (de) * 1988-12-20 1996-11-14 Clarity Technologies Inc Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen

Also Published As

Publication number Publication date
AU7444891A (en) 1991-09-18
SE9000595L (sv) 1991-08-21
WO1991013360A1 (en) 1991-09-05
SE468168B (sv) 1992-11-16

Similar Documents

Publication Publication Date Title
NZ219113A (en) Hiv peptide containing epitope of the env protein
SE8704185D0 (sv) Nya peptider, artificiella antigener och immunoanalystestsatser
SE9000595D0 (sv) New peptides, diagnostic antigens and an immunoassay method
ES2171414T3 (es) Inmunoensayos para anticuerpos anti-hcv utilizando antigenos con epitopos conformacionales.
DE3265768D1 (en) A method and a kit for the assay of antibodies to soluble antigens
ATE128738T1 (de) Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene.
US6686169B2 (en) Reagent for the detection of Staphylococcus aureus by agglutination
ES520012A0 (es) Procedimiento de aglutinacion con latex para la deteccion o la determinacion de un participante en una reaccion inmunologica.
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
McArthur et al. A rapid micro-method for screening eel sera for antibodies against the digenean Telogaster opisthorchis Macfarlane, 1945.
SE9101863D0 (sv) Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
RU2137138C1 (ru) Диагностическая композиция для определения сифилиса и тест-система "аквасиф" на ее основе
EP0951646B1 (en) THE IMMUNOENZIMATIC ASSAY FOR THE DIAGNOSIS OF EQUINE INFECTIOUS ANEMIA VIRUS DISEASE BY USING RECOMBINANT PROTEIN (rGP90) DERIVED FROM EQUINE INFECTIOUS ANEMIA VIRUS
SE8903985D0 (sv) New peptides, diagnostic antigens and an immunoassay
JPH05507559A (ja) 抗ｈｉｖ―１抗体に関するイムノアッセイ
ATE281471T1 (de) Antikörper-testbesteck zur bestimmung von amylin
Schmeer Answer to the commentary of Dr. Heyermann
Portetelle et al. Competition enzyme-linked immunosorbent assay(ELISA) for the diagnosis of bovine leukemia virus infection.
ES2075803A1 (es) Procedimiento de la deteccion de neumolisina
RU95113201A (ru) Способ выявления факторов высокого риска развития катаракты, набор реактивов для его осуществления и способ выявления больных

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9000595-0

Format of ref document f/p: F